We Can Medicines Co., Ltd. (TPEX:6929)

Market Cap	1.01B -31.1%
Revenue (ttm)	3.21B -1.1%
Net Income	-78.03M
EPS	-1.73
Shares Out	45.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,455
Open	21.85
Previous Close	22.35
Day's Range	21.35 - 21.85
52-Week Range	21.00 - 36.50
Beta	-0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About We Can Medicines

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1972
• Employees: 1,020
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6929

Financial Performance

In 2025, We Can Medicines's revenue was 3.22 billion, a decrease of -1.45% compared to the previous year's 3.27 billion. Losses were -73.21 million, 55.2% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 10, 2026

Data Sources Report a data error